1. Home
  2. SGHT vs GRAF Comparison

SGHT vs GRAF Comparison

Compare SGHT & GRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • GRAF
  • Stock Information
  • Founded
  • SGHT 2011
  • GRAF 2021
  • Country
  • SGHT United States
  • GRAF United States
  • Employees
  • SGHT N/A
  • GRAF N/A
  • Industry
  • SGHT Medical Specialities
  • GRAF
  • Sector
  • SGHT Health Care
  • GRAF
  • Exchange
  • SGHT Nasdaq
  • GRAF NYSE
  • Market Cap
  • SGHT 304.4M
  • GRAF 288.9M
  • IPO Year
  • SGHT 2021
  • GRAF 2024
  • Fundamental
  • Price
  • SGHT $3.90
  • GRAF $10.09
  • Analyst Decision
  • SGHT Buy
  • GRAF
  • Analyst Count
  • SGHT 7
  • GRAF 0
  • Target Price
  • SGHT $6.27
  • GRAF N/A
  • AVG Volume (30 Days)
  • SGHT 222.1K
  • GRAF 56.6K
  • Earning Date
  • SGHT 11-07-2024
  • GRAF 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • GRAF N/A
  • EPS Growth
  • SGHT N/A
  • GRAF N/A
  • EPS
  • SGHT N/A
  • GRAF 0.25
  • Revenue
  • SGHT $79,543,000.00
  • GRAF N/A
  • Revenue This Year
  • SGHT $2.18
  • GRAF N/A
  • Revenue Next Year
  • SGHT $8.14
  • GRAF N/A
  • P/E Ratio
  • SGHT N/A
  • GRAF $40.59
  • Revenue Growth
  • SGHT N/A
  • GRAF N/A
  • 52 Week Low
  • SGHT $2.93
  • GRAF $9.03
  • 52 Week High
  • SGHT $8.45
  • GRAF $11.02
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 40.94
  • GRAF N/A
  • Support Level
  • SGHT $3.65
  • GRAF N/A
  • Resistance Level
  • SGHT $4.12
  • GRAF N/A
  • Average True Range (ATR)
  • SGHT 0.19
  • GRAF 0.00
  • MACD
  • SGHT 0.07
  • GRAF 0.00
  • Stochastic Oscillator
  • SGHT 31.25
  • GRAF 0.00

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About GRAF GRAF GLOBAL CORP

Graf Global Corp is a blank check company.

Share on Social Networks: